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Bacteriophage B3 is a transposable phage ofPseudomonas aeruginosa. In this report, we present the complete 
DNA sequence and annotation of the B3 genome. DNA sequence analysis revealed that the B3 genome is 38,439 
bp long with a G+C content of 63.3%. The genome contains 59 proposed open reading frames (ORFs) 
organized into at least three operons. Of these ORFs, the predicted proteins from 41 ORFs (68%) display 
significant similarity to other phage or bacterial proteins. Many of the predicted B3 proteins are homologous 
to those encoded by the early genes and head genes of Mu and Mu-Iike prophages found in sequenced bacterial 
genomes. Only two of the predicted B3 tail proteins are homologous to other well-characterized phage tail 
proteins; however, several Mu-Iike prophages and transposable phage D3112 encode approximately 10 highly 
similar proteins in their predicted tail gene regions. Comparison of the B3 genomic organization with that of 
Mu revealed evidence of multiple genetic rearrangements, the most notable being the inversion of the proposed 
B3 immunity/early gene region, the loss of Mu-Iike tail genes, and an extreme leftward shift of the B3 DNA 
modification gene cluster. These differences illustrate and support the widely held view that tailed phages are 
genetic mosaics arising by the exchange of functional modules within a diverse genetic pool. 
Bacteriophage B3 is a temperate, transposable phage of eral species are known to play important roles in elemental 
Pseudomonas aeruginosa that was isolated from a pathogenic cycling. P. aeruginosa is commonly found in soil and water and 
strain of P. aeruginosa (strain 3) containing four different is one of the best-characterized members of the genus. P. 
prophages: A3, B3, C3, and D3 (38). These four phages are aeruginosa strain PAOI has been extensively studied and is 
serologically dissimilar and display no prophage cross immu­ used as the model strain for Pseudomonas genetics (37, 39, 75). 
nity (38). B3 is not induced by UV irradiation and can trans­ The complete genomic sequence of P. aeruginosa strain PAOI 
duce genes when using P. aeruginosa strain 1 (PAOl) as the was finished in 2000 (85). Several Pseudomonas plasmids have 
donor and recipient strain (38). DNA hybridization and re­ also been characterized, including some isolated by selective 
combination studies showed that B3 is somewhat related to growth enrichment and others specifically constructed for the 
other P. aeruginosa transposable phages, such as B39 and degradation of petroleum hydrocarbons and other toxic chem­
D3112, and to the transposable Escherichia coli phage Mu (2, icals (1, 15, 30, 47, 92). Thus, there is significant potential for 
49-51). Phages B3, D3112, and B39 also possess similar sero­ use of P. aeruginosa for bioremediation of contaminated envi­
logical characteristics (3). Like many other transposable ronments. 
phages, B3 integrates its linear genome essentially randomly In addition to its metabolic capability and environmental 
into the host chromosome during both lytic and lysogenic de­ versatility, P. aeruginosa is also studied because of its ability to 
velopment, often causing mutations in host genes (9, 50, 90). In cause human disease and its resistance to many antibiotics (7, 
addition, B3 and many other transposable phages carry essen­ 12, 27, 52). P. aeruginosa is an opportunistic pathogen that 
tially random host DNA fragments on the ends of the pack­
causes infections at a number of sites, including the urinary 
aged genome and have identical terminaI5'-TG dinucleotides tract, respiratory system, and central nervous system (7, 12). (2,49,74,90). Unlike Mu, B3 adsorption requires bacterial pili The success of P. aeruginosa as a pathogen can be attributed to 
and surface growth (74). Electron micrographs of B3 show it is its large number of virulence factors, including those that con­
morphologically distinct from Mu (24, 84). Both are tailed fer weakened host defenses, resistance to antibiotics, and pro­phages with a regular polygonal head; however, B3 displays a duction of extracellular enzymes and toxins (18, 45, 67, 73). flexible, noncontractile tail (84), while Mu possesses a rigid, The ongoing analysis of the factors that contribute to P. aerugi
contractile tail structure (24). Prior to this work, little was 
nosa virulence hold promise for the development of betterknown about the sequence or organization of B3 genes. 
antibiotics and methods for treatment of such infections (26, Multiple species of the genus Pseudomonas are commonly 79,80).found in the environment. This subset of the gamma-pro­ In this investigation, the genome of bacteriophage B3, a
teobacteria is metabolically and catabolically diverse, and sev­
transposable phage of P. aeruginosa, was sequenced, analyzed, 
and compared to the genomic sequences of Mu (68) and mul­
tiple Mu-like prophages (10, 20, 32–34, 48, 70–72, 83). 
MATERIALS AND METHODS 
Plasmids, phage, and bacterial strains. Bacteriophage B3 (ATCC 15692-B1) 
and the host bacterium, P. aeruginosa strain PAO1 (ATCC 15692), were obtained 
from the American Type Culture Collection (Manassas, Va.). The cloning vector 
pPCR-Script Amp, a derivative of pBluescript, and the E. coli XL1-Blue trans­
formation recipient (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac/F� proAB 
lacIq �lacZM15 Tn10 were obtained from Stratagene (La Jolla, Calif.). 
Phage DNA isolation, cloning, and sequencing. Phage B3 was propagated for 
DNA extraction using the P. aeruginosa PAO1 host and a plate lysate method in 
which the phage-infected cells are suspended in a soft agar overlay (66). After the 
agar overlay was harvested and subjected to centrifugation to remove agar and 
cell debris, the supernatant was treated with DNase and RNase (Sigma, St. 
Louis, Mo.) and the phage particles were concentrated by precipitation with 
polyethylene glycol 8000 (Fisher Biotech) and resuspended in SM buffer (66). 
Phage DNA was then isolated by phenol extraction and ethanol precipitation 
(76). The phage DNA was sheared, treated with Bal 31 exonuclease (Promega, 
Madison, Wis.), and fractionated on a 0.7% SeaPlaque agarose gel (FMC Cor­
poration, Newark, Del.), and fragments in the 1.6- to 3-kb range were puriﬁed 
using a Qiaex II gel extraction kit (QIAGEN, Valencia, Calif.) (76) and cloned 
into pPCR-Script Amp using a PCR-Script cloning kit (Stratagene). After E. coli 
XL1-Blue cells (Stratagene) were transformed and plated on Luria-Bertani agar 
containing ampicillin (50 �g/ml; Fisher Scientiﬁc, Hanover Park, Ill.), X-Gal 
(5-bromo-4-chloro-3-indolyl-�-D-galactopyranoside) (80 �g/ml; Fisher Scien­
tiﬁc), and IPTG (isopropyl-�-D-thiogalactoside) (20 mM; Fisher Scientiﬁc), 
white colonies were puriﬁed, cultures were grown, and plasmid DNA was iso­
lated using an UltraClean plasmid mini-prep kit (Mo Bio Laboratories, Solana 
Beach, Calif.). Plasmid inserts were sequenced from both ends using standard T3 
and T7 primers and Dye Terminator chemistry (PE Applied Biosystems, Foster 
City, Calif.) on ABI Prism 373 and 377 automated DNA sequencers (PE Applied 
Biosystems). For direct B3 genome sequencing, custom primers were designed 
from the assembled clone sequences using PrimerSelect software (DNASTAR, 
Inc., Madison, Wis.), and the sequence was determined using an ABI Prism 377 
automated DNA sequencer (PE Applied Biosystems). 
Sequence assembly and annotation. Genome analysis was performed using the 
Lasergene software suite (DNASTAR, Inc.). The processed sequences were 
aligned and edited using SeqMan II and coding regions were predicted using 
GeneQuest. Where multiple open reading frames (ORFs) were possible, the 
presence of ribosome-binding sites, codon bias, and genetic overlap were used to 
help choose the ﬁnal ORF presented. Searches of public databases for homol­
ogous DNA sequences were performed with BLASTN; whereas searches for 
protein sequence homologues were performed with BLASTP, BLASTX, PSI­
BLAST, and TBLASTX (4, 5; http://www.ncbi.nlm.nih.gov/BLAST). 
Variable host DNA sequences were identiﬁed by using a BLASTN search 
against the P. aeruginosa genome and the entire nonredundant GenBank se­
quence database. Searches for helix-turn-helix motifs were performed using GYM 
(69; http://www.cs.ﬁu.edu/�giri/bioinf/GYM2/prog.html), and searches for potential 
regulatory protein-binding sites were performed with BIOPROSPECTOR (54; 
http://robotics.stanford.edu/�xsliu/BioProspector/). 
Nucleotide sequence accession number. The DNA sequence of the B3 genome 
was deposited in the GenBank data bank and has been assigned accession 
number AF232233. 
RESULTS AND DISCUSSION 
Determination of the B3 genome sequence. The complete 
DNA sequence of the B3 genome was determined by using a 
shotgun sequencing approach. Phage B3 DNA fragments (1.6 
to 3 kb long) were ligated into pPCR-Script Amp plasmid 
vector DNA. After transformation of E. coli, the plasmids were 
recovered and their inserts were sequenced from both ends using 
vector primers and automated DNA sequencers. The B3 se­
quences were assembled using SeqMan II software (DNASTAR, 
Inc.), creating a genome scaffold. Direct B3 genome sequencing 
with 91 custom primers was used to ﬁll in gaps, resolve ambigu­
ities, and validate the assembled genome; upon completion, direct 
genome sequence data covered approximately 83% of the B3 
genome. 
A combined total of 655 plasmid and direct genome se­
quences were used to assemble the complete B3 genome. The 
average sequence, after end trimming and vector removal, was 
578 bases long. Each nucleotide position was sequenced a 
minimum of two times, in general at least once from each 
strand. When a nucleotide position was sequenced twice from 
a single strand, both cloned DNA and direct genome sequenc­
ing were used. Only 1.8% (720 bp) of the complete genome 
was represented by single-strand coverage. On average, each 
nucleotide position was sequenced 9.85 times, with 336 se­
quences representing the upper DNA strand and 319 se­
quences covering the lower strand. The linear genome is com­
posed of 38,439 bp (GenBank accession number AF232233) 
with a G�C content of 63.3%. This high G�C content corre­
lates with that of P. aeruginosa strain PAO1, which displays a 
G�C content of 66.6% in most predicted coding regions (85). 
Characterization of the ends of the B3 genome and attached 
host DNA. Assembly of multiple right-end sequences from 
plasmid clones revealed a position-speciﬁc divergence in se­
quence homology that deﬁned the right end of the B3 genome. 
Since only one clone contained B3 left-end DNA, this ap­
proach could not be used to deﬁne the precise genome left 
end. Therefore, direct genome sequencing of B3 DNA isolated 
from phage particles was performed with a primer walk-out 
strategy analogous to that used previously for Mu (44). The 
resulting sequences showed a loss of speciﬁc base identiﬁcation 
immediately 5� to terminal 5�-TG dinucleotides at both ends of 
the B3 genome (data not shown). We interpret this loss of base 
identity to be due to host DNA attached to the terminal 5�-TG 
dinucleotides, since all bases would be represented in nearly 
equal proportions if random host DNA segments were present 
at the ends of the B3 genome. These results conﬁrmed previ­
ous ﬁndings for B3 (50, 74). 
The presence of Pseudomonas DNA on both ends of the 
packaged B3 genome was conﬁrmed by performing a search 
for nucleotide sequence homologues by BLASTN analysis (5) 
of B3 left- and right-end clones. Sequences of the putative host 
DNA in the one left-end clone and three right-end clones 
displayed nearly perfect homology with different regions of the 
PAO1 genome, as expected for a transposable phage. In all 
cases, host homology ceased precisely at the 5�-TG B3 end. 
Nine clones lacking B3 homology contained sequences homol­
ogous to different regions of the PAO1 genome (data not 
shown). These clones were most likely derived by cloning of 
host DNA from the ends of B3 phage particle DNA or from 
particles containing only transducing DNA. 
BLASTN analysis of the B3 genome. The B3 genome was 
screened for nucleotide sequence homology with bacterial, 
bacteriophage, and viral DNA sequences using BLASTN anal­
ysis (5). Signiﬁcant nucleotide homology was found for only 
two regions of the B3 genome. The ﬁrst region reﬂected strong 
homology (expect value of 5e-24; 83% identity over 178 bp) 
between a region of bacteriophage �E125 (93) and ORF48 of 
B3. As will be discussed later, these homologous regions com­
prise about one-quarter of the dam DNA modiﬁcation genes 
of both phages. 
The second region consisted of the last 111 bp (bp 38328 to 
38439) of the B3 genome, which displayed strong homology 
(expect value of 2e-41) with a sequence containing the PAO1 
cyanide-insensitive oxidase A and B operon (cioAB; GenBank 
accession number Y10528; 19), but no homology with the se­
quenced PAO1 genome (85). Analysis of this 2,925-bp cioAB 
sequence by BLASTN against the PAO1 genome revealed 
strong homology with cioAB bp 1 to 2812 (corresponding to bp 
4403831 to 4406643 in the PAO1 genome; 19, 85). However, 
the remaining 113 bases of the cioAB sequence shared no 
similarity with the PAO1 genome sequence but displayed 
nearly perfect homology with the right end of the B3 genome 
(106 of 113 nucleotides [nt]). This region of B3/cioAB homol­
ogy lies 59 bp downstream of the termination codon of the cioB 
gene, with an orientation such that the right end of the B3 
genome is closest to cioB. The simplest explanation is that 
there is a B3 or B3-like prophage or a cryptic B3-like sequence 
downstream of cioB in the PAO1 substrain (PAO6049) from 
which the cioAB sequence was obtained (19). 
Assignment of probable B3 genes. Putative ORFs within 
the B3 genome were located using GeneQuest software 
(DNASTAR, Inc.) and validated by multiple methods. The 
predicted protein sequences were used for BLASTP analysis 
(5) to identify ORFs displaying signiﬁcant homology with 
other bacteriophage or bacterial protein sequences. Seg­
ments of B3 nucleotide sequence were also subjected to 
BLASTX analysis (5) to screen for possible homologues in 
other B3 reading frames. Sequence upstream and in the 
early portion of each predicted ORF was examined manu­
ally for the presence of ribosome-binding site sequences 
(e.g., GGAGG) (57) within 4 to 14 bases upstream of po­
tential start codons. The sequence was also examined for the 
close proximity of start codons to stop codons, as is fre­
quently observed in prokaryotic operons (57). When multi­
ple possible ORFs were present, codon usage was used to 
aid the choice of the most likely coding region. As observed 
for many organisms with high G�C DNA (16), most B3 
ORFs show a strong preference for G�C in the  ﬁrst and 
third base positions, with the second position displaying a 
preference for A�T (Table 1). Interestingly, the 1.5-kb re­
gion from 10.0 to 11.5 kb on the B3 genome exhibits less 
striking preference and has a lower G�C content, 53.9% 
instead of 63.3%, which may reﬂect its relatively recent 
incorporation into the genome. 
The above analysis identiﬁed 59 putative B3 protein-coding 
regions whose salient characteristics are given in Table 1. The 
ORFs are numbered 1 to 58 starting at the left end of the 
phage genome (and include a second nested protein-coding 
region ORF36Z within ORF36). In 13 cases where start site 
features were poor, alternative possible start sites are also 
given; they are designated with � and � symbols in Table 1. Six 
ORFs are predicted to encode very short polypeptides with 
fewer than 50 amino acids, and seven others would encode 
polypeptides only 50 to 90 amino acids long. Four potential 
translation initiation codons were identiﬁed: AUG (43 exam­
ples), GUG (10 examples), CUG (4 examples), and UUG (1 
example). Many of the non-AUG start codons are located in 
the putative late gene region (ORF24 to ORF58) and may 
reﬂect the use of rare initiation codons as a translational reg­
ulatory mechanism for some B3 genes. Since 6 of the 13 short 
ORFs begin with non-AUG start codons, it is also possible that 
some of these ORFs may not encode protein products at all 
but may be nonfunctional gene remnants generated during the 
evolutionary process. 
Detection of homologues and prediction of gene function. 
With the availability of genome sequences for many character­
ized bacteriophages, one fruitful approach for predicting pro­
tein function is the detection among homologous proteins 
some whose functions are already known. To take advantage of 
this approach, we performed homology searches with BLASTP 
and PSI-BLAST algorithms (4, 5) against protein sequences in 
the protein database at the National Center for Biotechnology 
Information (NCBI) (http://www.ncbi.nlm.nih.gov). BLASTP 
and the ﬁrst round of PSI-BLAST perform similar searches 
and were run with and without a low-complexity ﬁlter, respec­
tively. In most cases, the homologues identiﬁed and scores 
obtained were similar (see Table S2 in the supplemental ma­
terial). The second iteration of PSI-BLAST incorporates se­
quence information from the strong homologues identiﬁed in 
the ﬁrst round for a second search, with the consequence that 
scores for the ﬁrst homologues usually increase and new ho­
mologues are detected (4). The results showed that many B3 
genes are similar to genes in Mu and Mu-like prophages (de­
ﬁned as prophages that encode transposase homologues and a 
substantial number of other Mu protein homologues in the 
early, lysis, and head gene regions) (see Table S2 in the sup­
plemental material). The identity of the highest scoring homo­
logue and the homologue most useful in predicting the gene’s 
function are shown in Table 1, with their scores presented as 
expect values, which roughly indicate the likelihood of the 
observed match occurring at random. For B3 genes with ho­
mologues of known function, we were able to assign predicted 
functions, which are shown in Fig. 1. 
(i) Immunity and early genes. Predicted ORFs 1 to 15 ap­
pear to constitute a single operon which is transcribed leftward 
from a regulatory region located between ORF15 and ORF16. 
On the basis of their similarity to proteins involved in trans­
position, B3 ORF11 and ORF12 are predicted to encode the 
two transposase subunits analogous to the B and A proteins of 
Mu, respectively (Table 1 and Fig. 1; see Table S2 in the 
supplemental material). Likewise, B3 ORF1 and ORF2 are 
homologues of the Mu regulatory proteins Mor and GemA. 
These similarities lead us to propose that ORFs 1 to 15 con­
stitute the primary B3 early operon. The only other early 
operon protein for which a function can be proposed is that of 
ORF14, which exhibits similarity to two proposed transcrip­
tional regulators (Table 1; see also Table S2 in the supplemen­
tal material). On the basis of its location upstream of the 
transposase genes, ORF14 may encode the B3 lytic phase 
repressor analogous to the Mu Ner protein responsible for 
down-regulating early transcription and repressor transcription 
at late times during the lytic cycle (89). Of the remaining B3 
early operon ORFs, ﬁve had no detectable homologues 
(ORF3, -4, -7, -9, and -10) and the remaining ﬁve had bacterial 
(ORF5 and -8) or prophage (ORF5, -6, -13, and -15) homo­
logues of unknown function (see Table S2 in the supplemental 
material). The early operon of phage Mu also contains a num­
ber of relatively small genes of as yet unknown function (Fig. 
1). 
The untranslated region between ORF15 and ORF16 con­
tains a typical bacterial promoter, with a �35 hexamer (TTG 
CCA) separated by 16 nt from a �10 hexamer (TTTGTT) 
TABLE 1. Proposed B3 coding regions 
Gene Start positiona RBS
b Start 
codon 
Size 
(aa)c 
ORF codon usage (avg 
G�C %)d 
Base Base Base 
Representative homologue(s)e BLASTP expect valuef 
PSI-BLAST2 
expect valueg 
1 2 3 
Lefth 
ORF1 486 GGAGG (5) ATG 120 65.0 35.9 70.8 VioMu transcriptional regulator 1e-04 8e-38 
CV2165, AAQ59838 
Mu transcription activator Mor/ 0.91 3e-08 
E17, VMOR_BPMU 
ORF2 1052 GGAGG (6) ATG 187 70.6 39.1 82.9 Pnm2* hypothetical protein 6e-12 2e-48 
NMA1301, CAB84553 
Mu protein Gem/E16/gp16, 0.001 2e-19 
VG16_BPMU 
ORF3 1506 GAGG (9) ATG 155 71.0 47.7 75.5 — — — 
ORF4 1966 GAAG (6) ATG 152 69.0 42.8 64.5 — — — 
ORF4�i 1888 AGGGGG (6) GTG 126 72.2 34.9 60.3 ND ND ND 
ORF5 2534 AAGAAG (9) ATG 214 67.3 45.8 82.8 Conserved protein RL111 in 4e-33 1e-78 
PAPI-1, AAP84235 
Sti3 hypothetical protein 5e-24 5e-68 
STY1595, AH0683 
ORF5� 2579 GGGGG (6) ATG 229 66.4 43.6 83.0 ND ND ND 
ORF6 3204 AAGAGG (9) ATG 207 67.6 38.2 78.2 DucMul conserved protein 1e-56 9e-90 
HD0097, AAP95100 
ORF7 3397 GGAGG (9) ATG 66 57.6 44.0 74.3 — — 
ORF8 3764 GGAGG (8) ATG 124 69.4 48.4 75.0 Hypothetical protein RL112 in 3e-08 1e-36 
PAPI-1, AAP84236 
ORF8� 3824 GGAG (4) GTG 144 70.8 51.4 71.5 ND ND ND 
ORF8�� 3983 ATGAG (8) CTG 197 76.1 54.3 58.9 ND ND ND 
ORF9 4045 AGGAG (7) ATG 93 63.5 31.2 88.2 — — 
ORF10 4383 AGGGGG (7) ATG 113 70.8 46.0 75.2 — — 
ORF11 5557 AGGAGG (6) ATG 390 67.7 39.0 79.2 VioMu conserved protein e-119 e-139 
CV2157, AAQ59830 
General secretion pathway 4e-07 1e-71 
ExeA, GSPA_AERHY 
Mu transposase protein B, 0.004 0.001 
VPB_BPMU 
Tn552 transposase subunit — 0.019 
TnpB, S11779 
ORF12 7338 GGAG (6) ATG 593 66.0 44.5 79.6 Sti3 hypothetical protein 0.0 0.0 
STY1604, AI0684 
RadMu transposase DRA0075, 1e-05 3e-79 
E75601 
Tn552 transposase subunit — 2e-20 
TnpA, S11780 
ORF13 8267 AGGGG (5) ATG 308 72.1 39.3 75.0 BorMu NMB1002-like protein 9e-71 e-105 
BB3646, CAE35619 
ORF14 8586 GGAG (5) ATG 102 63.8 43.2 80.4 BorMu NMB1003-like protein 7e-23 1e-31 
BB3645, CAE35618 
Transcription regulator 7e-04 2e-16 
AGR_L_810, G98181 
ORF15 9064 GGAG (8) ATG 161 66.4 44.7 81.4 VioMu hypothetical protein 5e-36 2e-77 
CV2153, AAQ59826 
ORF16 9683 GAGG (9) ATG 163 74.9 56.5 64.4 — — 
ORF17 9904 AGGAG (7) ATG 69 65.2 43.5 68.1 NeisMu2* hypothetical protein 3e-13 2e-22 
NMB1004, B81133 
DucMu3 hypothetical protein 1e-12 2e-18 
HD1538, AAP96324 
Rightj 
ORF18 9990 AGGCGG (5) GTG 136 62.5 52.9 51.4 RS6 transcription repressor 3e-12 5e-29 
RSc1907, CAD15609 
Phage P22 c2 repressor, 0.18 3e-08 
CAA60873 
ORF18� 10167 GAAGG (7) GTG 77 58.5 53.3 50.7 ND ND ND 
ORF19k 10030 GAGG (6) GTG 44 56.8 52.3 70.5 — — — 
ORF20 10406 TAAGGAG (7) GTG 195 56.4 40.5 55.9 — — — 
ORF21 11022 AGAAGG (6) ATG 36 44.4 44.5 66.7 — — — 
ORF22 11138 GTAGG (4) TTG 128 64.0 43.8 53.9 — — — 
ORF22� 11144 GTAGG (10) TTG 126 64.2 44.5 53.2 ND ND ND 
ORF22�� 11177 AGGATG (8) TTG 115 64.3 44.4 53.0 ND ND ND 
ORF23 11538 AGGGAG (5) ATG 21 66.6 42.9 71.4 — — — 
ORF24 11682 GGAG (7) ATG 98 66.3 49.0 85.7 BorMu membrane protein 1e-12 2e-20 
BB3639, CAE35612 
BcepMu holin protein 1e-04 3e-15 
BcepMu21; AAS47861 
Continued on following page 
TABLE 1—Continued 
Gene Start positiona RBS
b Start 
codon 
Size 
(aa)c 
ORF codon usage (avg 
G�C %)d 
Base Base Base 
Representative homologue(s)e BLASTP expect valuef 
PSI-BLAST2 
expect valueg 
1 2 3 
ORF25 11918 GGAGG (10) CTG 264 68.2 53.4 76.5 BorMu lytic transglycosylase 3e-68 ND 
BB3638, CAE35611 
ORF26 12709 GAGG (8) GTG 70 62.9 52.8 67.2 — — — 
ORF27 12908 GGAGG (4) ATG 203 74.4 50.7 75.9 Sti3 probable lipoprotein 2e-13 1e-62 
STY1611, AH0685 
BcepMu Rz, Rz1 proteins 0.007 1e-41 
BcepMu23, -24, AAS47863, 
-4 
ORF28 13523 AAGGGG (7) ATG 129 67.4 34.9 79.1 Stm7* inner membrane protein 9e-22 1e-31 
STM4216, AAL23040 
Sti3 membrane protein 2e-18 4e-34 
STY1612, AI0685 
ORF29 13902 GGAG (5) ATG 102 63.8 44.1 83.3 Sti3 hypothetical protein 4e-32 5e-40 
STY1613, AB0686 
Phage Mu gp26, VG26_BPMU 12 — 
ORF30 14207 AAGAAG (4) GTG 193 70.0 47.1 84.4 VioMu conserved protein 4e-39 2e-52 
CV2141, AAQ59814 
Phage Mu gp27, VG27_BPMU 9e-06 3e-09 
ORF30� 14216 AAGAAG (14) ATG 190 70.5 46.8 84.2 ND ND ND 
ORF31 14788 GGGG (8) ATG 486 62.9 42.6 82.9 RadMu conserved protein 2e-76 e-140 
DRA0094, H75603 
Mu large terminase subunitl 3e-28 e-148 
gp28, VG28_BPMU 
ORF32 16248 GGAGG (7) ATG 488 68.3 43.9 81.4 BorMu gp29-like protein e-153 0.0 
BB3631, CAE35604 
Phage Mu gp29, VG29_BPMU 2e-10 e-137 
ORF33 17714 GGAG (7) ATG 418 68.9 46.9 78.3 DucMu3 gp30-like protein 9e-53 3e-83 
HD1557, AAP96341 
Mu F protein gp30, 2e-29 e-128 
VPF_BPMU 
ORF34 18980 GAG (7) GTG 32 59.4 62.5 81.2 — — 
ORF35 19094 GGAGG (4) ATG 190 68.9 46.8 75.8 DucMu3 G-like protein 5e-30 2e-60 
HD1558, AAP96342 
Mu G protein, VPG_BPMU 0.002 3e-17 
ORF36 19857 GAAAAG (3) CTG 423 73.0 47.7 79.7 VioMu conserved protein 8e-58 e-120 
CV2135, AAQ59808 
BcepMu protease protein 1e-45 e-120 
BcepMu32, AAS47872 
ORF36� 20097 GGAGG (11) ATG 343 72.9 47.3 78.7 ND ND ND 
ORF36Zm 20664 AGCAGG (8) ATG 154 76.6 42.2 79.2 DucMu3 conserved protein 2e-11 3e-36 
HD1559, AAP96343 
BcepMu scaffold protein 7e-05 5e-26 
BcepMu33, AAS91496 
ORF37 21132 AAGGGAG (11) ATG 125 68.8 57.6 79.2 DucMu3 hypothetical protein 7e-17 3e-49 
HD1560, AAP96344 
ORF38 21521 AAGGAG (5) ATG 309 63.7 46.3 84.2 DucMu3 hypothetical protein e-105 e-144 
HD1561, AAP96345 
BcepMu capsid protein 2e-17 1e-75 
BcepMu34, AAS47873 
ORF39 22497 GGAG (8) ATG 209 77.1 45.0 76.1 — — 
ORF40 23126 GGAG (7) GTG 172 72.1 45.9 77.4 DucMu3 hypothetical protein 4e-31 7e-68 
HD1562, AAP96346 
Mu gp36, VG36_BPMU 0.079 2e-15 
ORF41 23646 GAAGG (9) ATG 154 70.8 45.4 74.1 DucMu3 hypothetical protein 1e-14 5e-44 
HD1563, AAP96347 
ORF42 24107 GGAG (5) ATG 68 61.8 41.2 83.8 DucMu3 hypothetical protein 0.17 ND 
HD1564, AAP96348 
ORF43 24317 AAGGAG (5) ATG 250 57.6 44.4 85.6 RS1 conserved protein 5e-36 2e-95 
RSc0863, CAD14565 
Sti3 tail sheath protein — 0.34 
STY1625, AF0687 
ORF44 25072 AAGGCCG (7) ATG 168 72.6 43.5 77.4 DucMu1 hypothetical protein 2e-11 9e-56 
HD0137, AAP95133 
ORF45 25596 ACGGA (11) CTG 43 72.1 28.0 67.5 — — — 
ORF45� 25575 — ATG 50 70.0 28.0 68.0 ND ND ND 
ORF45�� 25428 AAGGA (10) CTG 99 72.7 47.5 61.6 ND ND ND 
ORF46 25741 AAGGAAG (8) GTG 26 73.1 46.2 84.7 — — — 
ORF47 25863 AAGGTG (8) GTG 61 62.3 62.3 70.5 XccP1 small conserved protein 2e-11 1e-21 
XCC2968, AAM42240 
Mu Com translational 0.009 0.028 
regulator, VCOM_BPMU 
ORF47� 25818 — GTG 76 59.2 60.5 71.0 ND ND ND 
Continued on following page 
TABLE 1—Continued 
Gene Start positiona RBS
b Start 
codon 
Size 
(aa)c 
ORF codon usage (avg 
G�C %)d 
Base Base Base 
Representative homologue(s)e BLASTP expect valuef 
PSI-BLAST2 
expect valueg 
1 2 3 
ORF47�� 25851 AGCAGA (9) GTG 65 61.5 61.5 70.8 ND ND ND 
ORF48 26018 GGAG (4) ATG 264 63.2 42.5 78.8 BorMu modiﬁcation e-122 ND 
methylase BB3607, 
CAE35580 
Phage �E125 gp27 methylase, e-114 ND 
AAL40300 
ORF49 26894 — ATG 1,099 71.2 49.0 74.3 DucMu3 tail-length tape 1e-23 — 
measure HD1569, 
AAP96352 
Phage Mu gp42 tail-length — 7e-10 
tape measure, 
VG42_BPMU 
ORF49� 26921 AAGGA (11) CTG 1,090 71.2 49.1 74.3 ND ND ND 
ORF50 30136 GCAGG (7) CTG 337 62.0 50.0 80.8 DucMul hypothetical protein 1e-37 e-155 
HD0145, AAP95140 
ORF50� 30193 GGA (6) ATG 318 62.0 50.0 80.8 ND ND ND 
ORF51 31151 AGGAAG (7) ATG 307 59.0 49.6 76.5 DucMul hypothetical protein 6e-35 e-137 
HD0146, AAP95141 
ORF52 32077 GGTGG (10) ATG 568 68.2 48.3 81.5 DucMul conserved protein 4e-83 0.0 
HD0148, AAP95143 
ORF52� 32497 AGGAG (11) GTG 428 69.7 48.4 81.6 ND ND ND 
ORF52�� 32656 AGGAG (11) TTG 375 69.9 48.8 82.1 ND ND ND 
ORF53 33770 AGGAG (5) ATG 272 60.7 51.1 77.2 DucMul hypothetical protein 4e-35 3e-87 
HD0150, AAP95145 
ORF54 34598 AGGAG (5) ATG 76 56.5 43.4 79.0 DucMul hypothetical protein 2e-08 3e-24 
HD0151, AAP95146 
ORF55 34600 AGGAG (5) GTG 151 74.2 57.0 59.0 XfP6* hypothetical protein 2e-10 3e-33 
XF2116, E82599 
ORF55� 34825 AAGGGG (7) GTG 76 69.7 56.5 73.7 ND ND ND 
ORF56 35042 GGAGG (6) ATG 736 64.6 49.0 80.3 DucMu3 conserved protein e-132 0.0 
HD1580, AAP96361 
ORF57 37249 GGAGG (9) ATG 266 60.5 53.8 70.3 — — — 
ORF58 38128 AGGGATG (5) ATG 74 67.5 33.8 79.7 — — — 
a First nucleotide of proposed initiation codon. 
b Identity of bases between ﬁrst and last matches to the ribosome-binding site (RBS) sequence UAAGGAGGUGA (57). The number of base pairs between position 
G in the above RBS sequence and base 1 of the initiation codon is shown in parentheses. 
c aa, amino acids. 
d ORF codon usage, measured by the average G�C content (as a percentage), at base positions 1, 2, and 3 of the codon. 
e In general, the homologues listed include the one with the greatest similarity and the one most useful for predicting the function of the B3 ORF. Homologue 
descriptions include the name of the phage or phage-related element (Table 2), the protein function if known, the ORF number or name, and an accession number, 
in that order. Homologue descriptions for proteins that are not phage associated begin with the protein function. —, no homologue with a score better than 5.0 was 
detected; ND, not determined. 
f BLASTP values were generated at NCBI (http://www.ncbi.nlm.nih.gov) with the low-complexity ﬁlter applied. —, no homologue with a score better than 5.0 was 
detected; ND, not determined. 
g PSI-BLAST expect values for iteration 2 were generated with the low-complexity ﬁlter turned off and with homologues scoring 0.005 or better in iteration 1. —, 
no homologue with a score better than 5.0 was detected; ND, not determined. 
h Genes transcribed leftward on map. 
i Alternate start sites are indicated by � and ��. 
j Genes transcribed rightward on map. 
k ORFs deemed least likely to function are shown in italics. 
l In the sequence databases (accession numbers AF083977 and NC_000929), Mu gp28 is mistakenly identiﬁed as a portal protein; gp28 is the large subunit of the 
Mu terminase (69, 83). 
m ORF36Z is entirely contained within ORF36 in the same reading frame and has the same function as Mu Z. 
(Fig. 2). The high similarity of this promoter to consensus to initiate rightward transcription. Examination of this region 
promoter sequences (�35 TTGACA, 16- to 18-nt spacer, and for a promoter driving leftward transcription revealed only two 
�10 TATAAT [29]) suggests that it will be recognized directly relatively poor candidates, one containing a �35 sequence 
by the host RNA polymerase and efﬁciently drive leftward (TTCACC) located 14 nt upstream of a �10 sequence (CAT 
transcription of the early operon. CTT) and a second containing a �35 hexamer (TTGACA) 
The untranslated region between ORF17 and ORF18 located 20 nt upstream of a �10 hexamer (TATTCA) (Fig. 2). 
should represent a second important regulatory region con- Whereas the hexamer sequences in these candidates are good, 
trolling both leftward transcription of ORF16 and ORF17 and the spacer distances are shorter and longer, respectively, than 
rightward transcription beginning with ORF18 (Fig. 1). This those of a typical good bacterial promoter (29, 65). Neverthe­
region contains another good candidate bacterial promoter, less, direct comparison of the effect of spacer length on pro-
with a �35 hexamer (TTGTGT) located 17 nt upstream of a moter activity in E. coli and P. aeruginosa revealed that longer 
�10 hexamer (AATATT) (Fig. 2). This promoter is oriented spacer lengths are tolerated in P. aeruginosa (65), making the 
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FIG. 1. Comparison of the genome organization for phages B3 and Mu. The genomes of B3 and Mu are shown as thick lines and are drawn approximately to scale, with tick marks 
at 1-kb intervals. ORFs are shown as boxes; their positions were derived from GenBank accession numbers AF083977 and NC_000929 for the Mu genome and this work for B3 
(GenBank accession number AF232233). The direction of transcription is indicated by an arrow; in addition, genes transcribed rightward are shown above the line, and those transcribed 
leftward are positioned below the line. Relevant Mu genes are identiﬁed by their gene names or sequential genome gp numbers, and functions if known. The predicted B3 gene functions 
shown were deduced from the known functions of homologous genes in Mu or other phages; for B3 genes with Mu homologues, the identity of the homologous Mu gene is also given. 
ORF17-18 Region
ORF15-16 Region
- - - TGGACGGCGCTCCAGAAGCCCCTCTGGCCGTCATCCAAACAAATAGCTGTTTTCACCGTTGGCAAAGCTGTTGCCACAGCGTCAGCCTGATGAGGTA
~~F1S ACCTGCCGCGAGGTCTTCGGGGAGACCGGCAGTAGGTTTGTTTATCGACAAAAGTGGCAACCGTTTCGACAACGGTGTCGCAGTCGGACTACTCCAT
= <=
CATTCACATTCGTCGGAGAGACTGACATGACTA~- - ­
GTAAGTGTAAGCAGCCTCTCTGACTGTACTGAT OR~~~
=> =>
- - - GGCGGTGGCTCCTGTAATGCAAAGATGTTGCGGGTTTGTGTGGTGAATAGTGGTGCCAAATATTGCACCTGTCAAGGCGGTTTAG - --~~F17 CCGCCACCGAGGACATTACGTTTCTACAACGCCCAAACACACCACTTATCACCACGGTTTATAACGTGGACAGTTCCGCCAAATC OR ~1_8_
= <=
ORF57-58 Region
ORFS7
=AAGCG'I"I"I"I'GATAATTGTGACCAACGTCTCC'I"I"I"I"I'GTACGGTCCTCAG - --
TTCGCAAAACTATTAACACTGGTTGCAGAGGAAAAACGATGCCAGGAGTC OR~~~
FIG. 2. Potential regulatory elements in untranslated regions. The sequences for both DNA strands in relevant predicted untranslated regions 
are shown. The beginning or end of the ﬂanking ORFs are shown by the large brackets; the ORFs continue in the directions of the broken lines. 
Potential �10 and �35 hexamers are indicated by bullets, which are pointed in the direction of transcription. 
second promoter a plausible candidate for driving transcrip­
tion of ORF16 and ORF17. 
One would expect these two untranslated regions to con­
tain binding sites for a B3 repressor protein that would keep 
early transcription turned off in a lysogen. Searches with 
BIOPROSPECTOR (54) identiﬁed multiple related se­
quences that overlapped all three promoters and, thus, 
might serve as repressor-binding sites, but we were unable to 
develop a single convincing consensus sequence from them. 
Nevertheless, there are two candidate ORFs that could en­
code the B3 immunity repressor protein, ORF17 and 
ORF18. The predicted protein encoded by ORF18 exhibits 
amino acid sequence similarity to the phage P22 c2 repres­
sor and a long list of predicted phage repressor proteins 
(Table 1; see Table S2 in the supplemental material). The 
putative ORF17 protein, while not homologous to known 
regulators, also contains a potential helix-turn-helix DNA-
binding motif (data not shown). The genes for both proteins 
lie close to the ORF17-ORF18 and ORF15-ORF16 inter-
genic regions where the immunity repressor is predicted to 
bind, a location consistent with the typically modular orga­
nization of phage genes and regulatory elements (8, 35). 
They are also just downstream of bacterial promoters and, 
thus, would be transcribed early after infection when repres­
sor protein synthesis is needed to establish lysogeny. The 
remaining ORFs in this region, ORF13, -15, -16, -20, -21, 
and -22 have no currently identiﬁable function. On the basis 
of their locations in predicted early transcripts, the proteins 
produced by these ORFs could function as (i) accessory 
regulators of repressor synthesis, (ii) positive regulators for 
subsequent phases of transcription, (iii) auxiliary factors 
regulating or involved in replication and transposition, and 
(iv) factors stimulating or inhibiting host functions affecting 
lysogenic or lytic development. 
(ii) Middle and late genes. It is well-known that phages and 
other viruses typically possess mechanisms that confer sequen­
tial expression of their genes. For example, genes for genome 
replication are usually expressed early in the lytic cycle, and 
genes for phage particle morphogenesis and cell lysis are ex­
pressed late. Phage Mu transcription occurs in three phases: 
early, middle, and late (60). Mu middle and late transcripts are 
activated by the Mor and C proteins, respectively (59, 63). 
The identiﬁcation of typical bacterial promoter sequences in 
the ORF15-ORF16 and ORF17-ORF18 intergenic regions 
makes it likely that transcription of ORF1 through ORF15, 
ORF16 and ORF17, and ORF18 through ORF23 occurs early 
during the lytic cycle and is catalyzed by the host RNA poly­
merase. Since the leftward promoter for transcription of 
ORF16 and ORF17 may be inefﬁcient due to its long 20-nt 
spacer, it is possible that a positive regulator produced from 
one of these transcripts might stimulate transcription from that 
region, making ORF16 and ORF17 the B3 middle genes. It is 
equally possible that ORF16 and ORF17 are simply early 
genes and that B3 has only two phases of transcription, early 
and late. 
The ﬁrst identiﬁable B3 late genes are ORF24, ORF25, and 
ORF27. The predicted ORF25 protein has strong amino acid 
sequence similarity to more than 50 soluble, predominantly 
bacterial, lytic transglycosylases (see Table S2 in the supple­
mental material), and therefore, likely encodes a B3 endolysin 
that participates in host cell lysis. With the recent release of the 
BcepMu sequence (GenBank accession number AY539836), 
we can also identify nearby ORF24 and ORF27, which encode 
potential membrane or membrane-anchored proteins, as ho­
mologues of the predicted BcepMu holin and Rz homologues, 
proteins predicted to play roles in host cell lysis analogous to 
those of the well-studied auxiliary lysis proteins of phage 
lambda (6). 
Most of the ORFs from ORF28 through ORF38 are the 
head genes of B3; they display signiﬁcant amino acid sequence 
similarity and gene order with the known head genes of Mu 
(22, 25, 68) (Table 1 and Fig. 1; see Table S2 in the supple­
mental material). In particular, ORF30 and ORF31 are ho­
mologous to the small and large subunits of the Mu terminase 
(68, 82) and are followed by the portal and head assembly 
genes ORF32 and ORF33, respectively. In Mu, the head as­
sembly gene is followed by the Mu G gene (gp31), and ORF35 
of B3 is a Mu G homologue. Although the precise role of Mu 
G protein is not known, it is proposed to be involved in head-
tail joining (25). In many tailed phages, including Mu, the 
overlapping genes for the protease and scaffolding proteins 
and the gene encoding the major capsid protein follow the 
above genes (68). On the basis of similarity to BcepMu pro­
teins (86), we can also identify ORF36 as the gene encoding 
the B3 protease and nested scaffolding protein (designated 
ORF36Z) and ORF38 as encoding the B3 major head protein, 
the capsid protein. Thus, the order of B3 head genes roughly 
parallels that in Mu and other tailed phages. 
In many phage genomes, a cluster of tail genes follows the 
head genes, with the tail-length tape measure gene being pre­
ceded by the tail sheath and tail tube genes (14, 68). Phage B3 
has the two-gene DNA modiﬁcation gene cluster located im­
mediately upstream of the predicted B3 tail-length tape mea­
sure gene, ORF49; however, ORF43 exhibits some similarity 
to the tail sheath protein of phage Sti3 (Table 1; see Table S2 
in the supplemental material), and other ORF43 homologues 
are closely related to other phage tail sheath proteins (data not 
shown). With the exception of ORF43 and ORF49 (and pos­
sibly ORF40, a homologue of Mu gp36 of unknown function), 
there is no signiﬁcant homology to any characterized phage tail 
genes. Since B3 has a ﬂexible noncontractile tail morphologi­
cally similar to that of phages lambda and A118 (46, 55, 84), 
one might expect approximately 10 B3 genes to be involved in 
tail morphogenesis. The right half of the B3 genome contains 
15 ORFs of as yet unidentiﬁed function (ORF40 through -42, 
ORF44 through -46, and ORF50 through -58). Excluding the 
very small ORFs (ORF45 and ORF46) and ORF58, which had 
no detectable homologue, there are 12 remaining B3 ORFs, 
and we predict that most of these are involved in B3 tail 
morphogenesis. After completion of the BLAST analysis, we 
discovered that genes at the right end of the phage D3112 
genome encode proteins with very high similarity to those from 
B3 ORF41 through ORF57, with the notable exception of 
ORF45 through ORF48, which include the B3 DNA modiﬁ­
cation gene cluster. These D3112 genes also have the same 
order as their B3 homologues (91). 
Examining the sequences in untranslated regions and very 
short ORFs between ORF22 and ORF57 both manually and 
with the program BIOPROSPECTOR (54), we failed to detect 
any consistent sequence elements that might serve as promot­
ers or binding sites for regulators of late transcription. We 
were also unable to detect elements which could form a po­
tential RNA stem-loop structure, followed by a string of T 
residues, features characteristic of Rho-independent termina­
tors (11). Thus, insight into possible regulatory sequences and 
mechanisms must await experimental determination of tran­
script ends within this late gene region. Interestingly, there is a 
poor, but recognizable, promoter just upstream of ORF58 
(Fig. 2), raising the possibility that it is a moron, an autono­
mous genetic module containing a protein-coding region 
ﬂanked by a promoter and terminator (41). 
(iii) DNA modiﬁcation gene cluster. The Mu DNA modiﬁ­
cation gene cluster contains two genes, com and mom, which 
are located at the extreme right end of the genome (Fig. 1). 
The Mom protein modiﬁes about 15% of the adenine residues 
in Mu DNA to acetamidoadenine, protecting it from cleavage 
by a variety of restriction enzymes (31, 42). In the absence of 
Com, translation of mom mRNA is inefﬁcient due to formation 
of a stem-loop structure that occludes the ribosome-binding 
site and start codon for Mom translation (31, 42). The Mu 
Com protein is a zinc ﬁnger protein that binds to an adjacent 
stem-loop structure, destabilizing the mom RNA stem-loop 
and allowing translation of Mom (31, 42). 
The B3 DNA modiﬁcation gene cluster also contains two 
genes: ORF47, which encodes a Com homologue containing 
the four highly conserved zinc ﬁnger cysteines, and ORF48 
which encodes a DNA adenine methyltransferase homologue 
(see Table S2 in the supplemental material). Folding of RNA 
sequences containing the translation initiation region of 
ORF48 using the Zuker (94) Mfold web server (http://www 
.bioinfo.rpi.edu/applications/mfold) produced a variety of 
structures depending on the length of sequence used. In these 
structures, the ORF48 ribosome-binding site bases GGAG 
were partially or completely sequestered in double-stranded 
regions (data not shown), leaving open the possibility that 
translation of ORF48 is similarly regulated. 
Global organization of the B3 genome: functional coding 
regions. Although there is signiﬁcant amino acid sequence 
similarity between proteins encoded by B3 and Mu, there are 
several differences in genome organization, with the most dra­
matic being the opposite orientations of their early operons 
(Fig. 1). In B3, the leftmost 9 kb containing the proposed 
primary early operon is transcribed leftward, whereas in Mu, 
the early genes are transcribed rightward (Fig. 1). 
The proposed B3 late genes are transcribed rightward, as are 
the Mu late genes, and the order of B3 head genes parallels 
that of the Mu head genes (Fig. 1). One notable difference 
between the B3 and Mu genome organization is the location of 
the B3 com-dam DNA modiﬁcation gene cluster within the tail 
gene region about 12 kb from the genome right end; the cor­
responding com-mom gene cluster of Mu is located at the 
extreme right end of the Mu genome (Fig. 1). 
B3 evolution. Homologues of B3 genes were found in a large 
array of phages, prophages, and phage-related elements (see 
Table S2 in the supplemental material). Table 2 lists the names 
of the phages, prophages, and phage-related elements with 
signiﬁcant homology to B3 genes, their hosts, and genome 
locations and reveals a dramatic increase in the number of 
Mu-like transposable phage family relatives since the annota­
tion of the Mu genome in 2002 (68). The hosts containing 
these prophages and elements, as well as their ecological 
niches, are quite diverse, ranging from nonpathogenic enteric 
bacteria, such as E. coli K-12 (87), to human or animal patho­
gens, including E. coli O157:H7 (32), Neisseria meningitidis (48, 
71, 88), Salmonella enterica (70), Bordetella bronchiseptica (72), 
Vibrio cholerae (33), Haemophilus inﬂuenzae (20), Burkholderia 
cenocepacia (86), and Haemophilus ducreyi (GenBank acces­
sion number NC_002940), to predominantly nonpathogenic 
soil organisms, such as Shewanella oneidensis (34) and Chro­
mobacterium violaceum (10), to plant pathogens, such as Xy­
lella fastidiosa (83). This diversity strongly supports the conclu­
sion that tailed phages are genetic mosaics derived by multiple 
stepwise recombinational exchanges that occur within a single, 
large gene pool for tailed phages (14, 35, 36). 
While B3, Mu, and multiple bacterial genome prophages are 
clearly closely related, the level of similarity varies greatly 
across the B3 genome (Fig. 3). The genes with the greatest 
similarity and highest frequency of homologues are located in 
the early and head regions. Consistent with the difference in 
tail morphology, homology with the Mu family was absent from 
TABLE 2. Phages, prophages, and phage-related elements with homology to phage B3a 
Phage or elementb Bacterial hostc Gene(s)d 
Phage A118 Listeria monocytogenes ORF1-ORF72 
Phage BcepMu Burkholderia cenocepacia gp1-gp53 
BorMu Bordetella bronchiseptica RB50 BB3606-BB3657 
Brs1* Brucella suis 1330 ?BR0584-BR0599? (ext) 
Bruc1* Brucella melitensis 16M BMEI1340-BMEI1350 
Cc1* Caulobacter crescentus CB215 ?CC2776-CC2790 (ext) 
CP-933T* Escherichia coli O157:H7 EDL933 Z2966-Z2994 
CV1* Chromobacterium violaceum ATCC 12472 CV0406-CV0432 
CV2* Chromobacterium violaceum ATCC 12472 ?CV1474-CV1479? 
Phage D108 
Phage D3112 
Escherichia coli 
Pseudomonas aeruginosa 
Probably 50 to 60 genese 
p01-p55f 
DucMu1 Haemophilus ducreyi 35000HP HD0089-HD0156 
DucMu2 Haemophilus ducreyi 35000HP HD0479-HD0540 
DucMu3 Haemophilus ducreyi 35000HP HD1517-HD1581 
FluMu Haemophilus inﬂuenzae Rd KW20 HI1476-HI1523 
Phage HF2 Haloferax volcanii ORF1-ORF121 
Phage K139 Vibrio cholerae ORF1-ORF44 
MiniFluMu* Haemophilus inﬂuenzae Rd KW20 HI1568-HI1571 
Phage Mu Escherichia coli gp1-gp55 
MuSo1 Shewanella oneidensis MR-1 SO0641-SO0683 
MuSo2 Shewanella oneidensis MR-1 SO2652-SO2704 
NeisMu1* Neisseria meningitidis B MC58 NMB1078-NMB1121 
NeisMu2*g Neisseria meningitidis B MC58 NMB0985-NMB0991 
NMB1* Neisseria meningitidis B MC58 NMB1002-NMB1007 
Pnm1 Neisseria meningitidis A Z2491 NMA1821-NMA1884 
Pnm2* Neisseria meningitidis A Z2491 NMA1281-NMA1330 
Pnm3* 
Pnm4/5*h 
Neisseria meningitidis A Z2491 
Neisseria meningitidis A Z2491 
NMA1185-NMA1199? 
NMA1208-NMA1231? 
Phage 03 Pseudomonas syringae DC3000 PSPTO3385-PSPTO3429 
Phage V Shigella ﬂexneri SfV ORF1-ORF53 
Phage 186 Escherichia coli ORF1-ORF97 
Phage P2 Escherichia coli ORF1-ORF42 
Phage �P27 Escherichia coli ORF1-ORF58 
Phage �E125 Burkholderia mallei ORF1-ORF70 
Phage PP01 Pseudomonas putida KT2440 PP3849-PP3920 
RadMu Deinococcus radiodurans R1 DRA0074-DRA0119 
RS1* Ralstonia solanacearum GMI1000 ?RSc0839-RSc0892? 
RS6 Ralstonia solanacearum GMI1000 RSc1896-RSc1948 
SP14* Escherichia coli O157:H7 Sakai ?ECs2713-ECs2774 
SP18 Escherichia coli O157:H7 Sakai ECs4943-ECs4998 
Sti3i 
Phage ST64B 
Stm7* 
Salmonella serovar Typhi CT18j 
Salmonella serovar Typhimuriumj 
Salmonella serovar Typhimurium LT2j 
STY1591-STY1643 
Sb1-Sb56 
STM4196-STM4219 
Tum2 Agrobacterium tumefaciens C58 AGR_C_1731-AGR_C_1774 
VibMu* 
VioMuk 
Vibrio cholerae N16961 
Chromobacterium violaceum ATCC 12472 
?VC1788-VC1803 (ext) 
?CV2111-CV2165? 
XacP1* Xanthomonas axonopodis 903 ?XAC 2640-XAC2655? (ext) 
XccP1 Xanthomonas campestris ATCC33913 XCC2962-3012 
XfP1 Xylella fastidiosa 9a5c XF0678-XF0733 
XfP4* Xylella fastidiosa 9a5c XF1642-XF1711 
XfP5* Xylella fastidiosa 9a5c XF0485-XF0536? 
XfP6* Xylella fastidiosa 9a5c XF2110-XF2132 (ext) 
a Much of the information given here for prophages and phage-related elements found in bacterial genome sequences was taken from the review by Casjens (13). 
The genome sequences for Bordetella bronchiseptica, Chromobacterium violaceum, and Haemophilus ducreyi were completed after that review; their B3-homologous 
prophages and elements are named here using the conventions of Morgan et al. (68) and Casjens (13). Speciﬁcally, new Mu-like prophages were named by adding a 
three-letter preﬁx to Mu (e.g., VioMu), and short phage-related elements are identiﬁed by a strain designator and asterisk (e.g., CV1*). For other phages and phage 
elements that were named by viral and bacterial genome sequencing teams, we use the names given by those teams. 
b The names of phages known to be capable of infection and multiplication are designated Phage. Elements that appear to be too short to allow independent 
multiplication are marked with an asterisk. Newly identiﬁed prophages with high homology to Mu are designated BorMu, DucMu (pronounced duke), and VioMu 
according to the convention of Morgan et al. (68). 
c For infectious phage, a common host is listed. For prophages and elements, the strain whose genome was sequenced is given. 
d The genes included in each phage, prophage, or element are listed using the genomic sequential ORF numbering system. A question mark is added when the 
terminal gene is uncertain. (ext) indicates that the identiﬁcation of B3-homologous genes has resulted in the extension of the likely outer limits of prophages and 
phage-related elements beyond those annotated by Casjens (13). 
e Phage D108 has not been sequenced, but it is very closely related to Mu (21); therefore, it probably has 50 to 60 genes. 
f The sequence database annotation for D3112 contains 55 genes, whereas the published paper lists only 53 genes (91). 
g NeisMu2 is also called MuMenB (62). 
h Pnm4 and Pnm5 were originally annotated as two separate elements (48, 71). Their close proximity and the identiﬁcation of intervening genes as B3 homologues 
suggest that they may be a single longer element that we call Pnm4/5. 
i Sti3 is also called SalMu (86). 
j The complete names for Salmonella species are as follows: Salmonella serovar Typhi is Salmonella enterica subsp. enterica serovar Typhi (strain CT18), and 
Salmonella serovar Typhimurium LT2 is Salmonella enterica serovar Typhimurium (strain LT2). 
k VioMu is also called ChromoMu (86). 
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FIG. 3. Diagrammatic representation of the degree of relatedness for B3 genes with homologues in other Mu-like phages and prophages. The B3 map, ORFs, and predicted protein 
functions are shown as in Fig. 1, except that all ORFs are shown above the kilobase line. Phages and prophages with homology to at least six B3 genes are included, and their names 
are listed on the left. Horizontal lines drawn below a B3 gene indicate the presence of a homologue in the corresponding Mu-like phage or prophage. The thickness of the line indicates 
the degree of similarity, achieved by dividing the BLAST expect values in Table S2 in the supplemental material into ﬁve groups, with the thickest line representing the greatest similarity 
(group I) and decreasing thickness indicating decreasing similarity. The expect value boundaries for the ﬁve groups are as follows: e-50 or better for group I, e-49 to e-15 for group II, 
e-14 to e-4 for group III, 0.001 to 5.0 for group IV, and �5.0 for group V on PSI-BLAST iteration 1 but 1.0 or better on PSI-BLAST iteration 2. 
the predicted tail region (see Table S2 in the supplemental 
material), but the three H. ducreyi prophages closely related to 
B3, DucMu1, DucMu2, and DucMu3 (Fig. 3), and D3112 (data 
not shown) exhibit high similarity across both predicted B3 tail 
gene regions. Consistent with the conclusion that proteins 
which function together are often grouped together in the 
genome, many of the B3-related phages and prophages in Fig. 
3 appear to have retained or lost the entire B3 head gene 
module or tail gene module rather than just a subset of those 
genes. The most notable exceptions are XfP5, Pnm2, and 
VibMu, which are known to be cryptic phage remnants lacking 
many phage genes (Table 2) (13). It remains to be determined 
whether the other exceptions are also defective or have simply 
evolved proteins that perform the same function but exhibit 
little amino acid sequence similarity, as observed previously for 
other phages, including the lambdoid phages HK022 and 
HK97 (41, 68). 
The Mu-like prophages shown in Fig. 3 all share the global 
gene organization of Mu, with early genes followed by lysis 
genes, then head genes, and ﬁnally tail genes. In most cases, 
the order of genes within these functional groups is also con­
served, and B3 hypothetical ORFs without homologues are 
replaced by different hypothetical ORFs in the other phages, 
although the number of such ORFs often varies. The inversion 
of the B3 early gene region relative to Mu allows us to divide 
the Mu-like phages and prophages into two groups. Those with 
rightward transcription of the early genes include Mu, FluMu, 
SP18, Pnm1, Pnm2, DucMu1, DucMu2, MuSo1, MuSo2, and 
D3112. Those which, like B3, have the early operon tran­
scribed leftward include BorMu, VioMu, DucMu3, Sti3, and 
BcepMu. Genes in prophages BorMu, VioMu, and DucMu3 
also exhibited the greatest similarity to B3 genes (Fig. 3). 
B3 transposase subunit evolution. The BLAST and PSI­
BLAST searches with ORF12 identiﬁed a number of homo­
logues in genomic Mu-like prophages and multiple annotated 
transposase proteins, including the primary transposase sub­
units of RadMu and Tn552 (Table 1; see also Table S2 in the 
supplemental material). The Tn552 transposase TnpA, like the 
Mu A protein, is a member of the DDE superfamily of trans­
posases that include retroviral integrases and the transposases 
of the IS3 family of bacterial insertion sequences (28, 53). This 
superfamily consists of a relatively heterogeneous group of 
proteins that share at least a �200-residue catalytic core and 
perform closely related strand transfer reactions (28, 53). De­
spite the lack of similarity to the Mu A transposase subunit, 
these homologies clearly identiﬁed ORF12 as encoding the 
primary transposase subunit for B3. Its location, in the early 
operon, also parallels that of the Mu A transposase (Fig. 1). 
Curiously, similar searches with ORF11 identiﬁed four dif­
ferent groups of proteins. Several of those with the greatest 
similarity were annotated as homologues of A subunits of the 
bacterial type II general secretion pathway (GSP) used for the 
second step of secretion of multiple hydrolytic enzymes and 
toxins from the periplasm to the extracellular environment (77, 
78). The second group contained true GSPA proteins. The 
third group contained the MshM proteins of the bacterial type 
IV MSHA (mannose-sensitive hemagglutination antigen) se­
cretion pathway used for synthesis of type IV pili and for 
transfer of DNA during conjugation and transfer of T-DNA 
into plant cells by Agrobacterium tumefaciens (17, 56, 61). Many 
of the type IV secretion pathway proteins are closely related to 
those of the type II pathway, and MshM shares homology with 
the GSPA component in particular (56). The fourth group, 
with considerably lower similarity, contained a number of 
transposase subunits similar to and including the Mu B and 
Tn552 TnpB transposase subunits. Strikingly, the proteins with 
the greatest similarity to B3 ORF 11 were encoded next to the 
Mu A protein homologue within BcepMu (86) and the closely 
related Mu-like prophages VioMu, DucMu (DucMu1, -2, and 
-3), BorMu, and VibMu, a position analogous to that of the B 
gene in Mu (Fig. 1). In the case of BcepMu, the B3 ORF11 
homologue (BcepMu gp8) has been annotated as ExeA and 
proposed to serve as a potential virulence factor for pathogen­
esis (86). In contrast, the similarities and locations described 
above lead us to propose that ORF11 and its phage and pro­
phage homologues encode the second transposase subunit 
analogous to Mu B, an ATPase subunit that brings the target 
DNA to the transposase complex (28, 64). 
The observed similarity of the transposase subunits to ATP-
binding subunits of the type II and type IV secretion systems is 
real. Beginning a PSI-BLAST homology search with each of 
the two best-characterized proteins, Mu B (64) and the Aero-
monas hydrophila type II secretion protein ExeA (also called 
GSPA) (40, 81), led to recovery of the same three groups of 
homologous proteins in the second iteration (data not shown). 
Furthermore, the conserved �150-amino-acid ATPase domain 
of the ExeA subunit (COG 3267) is located within the �300­
amino-acid conserved transposase ATPase subunit domain 
(COG 2842) (58; http://www.ncbi.nlm.nih.gov; data not 
shown). Whereas similarity of the 500- to 700-amino-acid 
GSPA secretion proteins to each other usually extended over 
the entire length of both proteins, similarity of the smaller 
�300-amino-acid type IV proteins and the 300- to 400-amino­
acid transposase subunits was generally limited to the N-ter­
minal 250 to 300 amino acids of ExeA. This region of ExeA 
contains the three motifs characteristic of ATPases, the 
Walker A motif, the Mg2�-binding site, and the Walker B 
motif (81). Thus, it seems likely that it is the related ATPase 
domains in these groups of proteins that are responsible for 
their detection as homologues. 
Clearly, the BLAST scores show that ORF11 of B3 and its 
prophage homologues are much more similar to the ATPase 
domains of the secretion genes than to the Mu B-like trans­
posase subunits (Table 1; see also Table S2 in the supplemental 
material); yet, like the transposase subunits, they are only 
�400 amino acids long. Perhaps the secretion proteins and 
ORF11 homologues evolved from a common ATPase ances­
tor, either by deleting the C terminus of a long protein pre­
cursor to form the transposase subunit or by adding 100 to 300 
amino acids to the ATPase domain to form the secretion pro­
tein, with the added region playing a secretion-speciﬁc role. 
Nevertheless, at this point, we cannot rule out the possibility 
that ORF11 and its prophage homologues participate in both 
transposition and protein secretion. A test of their ability to 
complement an exeA or mshM mutant is clearly warranted, as 
is a test for transposition of an ORF 11 mutant phage. 
B3 DNA modiﬁcation gene evolution. The B3 DNA adenine 
methylase gene, ORF48, was the only B3 gene with signiﬁcant 
nucleotide sequence similarity to any other phage or bacterial 
gene; it shares similarity with gene 27, the DNA adenine meth­
ylase gene, of the temperate phage �E125 of Burkholderia 
thailandensis (93). Not surprisingly, the amino acid sequences 
of the ORF48 and gene 27 proteins exhibited extremely high 
similarity over the entire length of both proteins. Very high 
protein similarity was also observed for the proteins annotated 
as DNA modiﬁcation methylases of the BorMu, VioMu, and 
phage 03 prophages of Bordetella bronchiseptica, Chromobac­
terium violaceum, and Pseudomonas syringae (see Table S2 in 
the supplemental material). There were about 70 additional 
ORF48 homologues; most were bacterial proteins and had 
considerably poorer scores. This group contained multiple 
methylase genes associated with restriction-modiﬁcation sys­
tems, e.g., MboI and DpnII, and multiple cytosine-speciﬁc 
methyltransferases as well. Thus, it remains to be seen whether 
ORF48 and its prophage homologues perform an adenine 
methylation or some other type of modiﬁcation and whether 
that modiﬁcation provides a survival advantage to the phage as 
Mom does for Mu (31, 42). 
Curiously, B3 is the only phage in Fig. 3 that encodes both 
Com and Dam homologues. Phages VioMu and BorMu en­
code Dam homologues, but no Com homologue (Fig. 3). 
Phages SP18, FluMu, and Mu encode Com homologues but no 
Dam homologue (Fig. 3). A BLASTP search with the Mu 
Mom protein sequence revealed that SP18 encodes a Mom 
DNA modiﬁcation protein just downstream of its com gene 
(data not shown), but as observed previously by Morgan et al. 
(68), FluMu encodes a different non-Mom-like protein at that 
position, as does Pnm1 (68). A BLASTP search with the 
FluMu protein sequence identiﬁed homologues in Pnm1 and 
Pnm2 as well as DucMu1, DucMu2, and DucMu3 (data not 
shown). The lack of similarity between these new genes and 
Mom or Dam raises the possibility that these genes may per­
form a DNA modiﬁcation different from both methylation and 
acetamidoadenine modiﬁcation. In Mu, the Com protein is 
needed to prevent translation of Mom until late in the lytic 
cycle, because high-level Mom expression is lethal (31, 43). 
The absence of intact Com homologues in these other phages 
(Pnm1 contains a mutant com gene [68]) suggests that expres­
sion of their DNA modiﬁcation genes may not be lethal, 
thereby making Com unnecessary. 
In Mu and all but one of the above phages, the DNA mod­
iﬁcation gene(s) is located very close to the right end of the 
phage genome, whereas in DucMu1 and B3, the DNA modi­
ﬁcation gene(s) is located internally, approximately 12 kb from 
the right end (data not shown). Thus, there are striking differ­
ences in the gene number, modiﬁcation protein sequence, and 
gene locations in this group of closely related phages. 
Summary. The sequencing of transposable phage B3 particle 
DNA revealed that B3 has a linear genome, 38,439 bp long, 
with variable host DNA fragments attached to the genome 
ends. Comparison of the B3 genetic map to that of Mu re­
vealed evidence of multiple genetic rearrangements and sub­
stitutions. The results from homology searches with the 59 
predicted B3 ORFs allowed us to predict potential functions 
for almost half of the genes, deﬁning distinct transposition, 
regulation, lysis, head, and tail regions. Homologous proteins 
were found in multiple related phages with a diverse range of 
bacterial hosts, raising the possibility that genetic manipula­
tions based on transposable phage technology (23, 90) can be 
applied to this broad spectrum of pathogenic and nonpatho­
genic bacteria. The sequence also provides much of the essen­
tial information needed for the development of B3 vectors for 
use in bioremediation. 
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